A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia
Objective: To evaluate the efficacy of extended-release quetiapine fumarate (XR) monotherapy once daily, in the treatment of patients with acute episodes of schizophrenia and agitation. Method: Our study was a 3-week open-label study conducted in adult in- or outpatients with schizophrenia. Quetia...
Saved in:
Main Authors: | Koh, Ong Hui, Sulaiman, Ahmad Hatim, Gill, Jesjeet Singh, Pillai, Subash Kumar, Jambunathan, Stephan Thevananthan, Rashid, Rusdi Abdul |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis
2013
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/9622/1/00000797_93562.pdf http://eprints.um.edu.my/9622/ https://doi.org/10.5455/bcp.20130127022922 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A 3-week, open label study to evaluate the efficacy and safety of extended release quetiapine fumarate in the treatment of agitation in patients with schizophrenia
by: Hui, Koh Ong, et al.
Published: (2013) -
Branch retinal vein occlusion associated with quetiapine fumarate
by: Ku, Chui Yong, et al.
Published: (2011) -
Safety and efficacy of rapid dose administration of quetiapine in bipolar mania
by: Hatim, A., et al.
Published: (2006) -
The effect of obsessive compulsive symptoms on psychopathology in patients with schizophrenia
by: Ng, Boon Seng, et al.
Published: (2018) -
An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia
by: Damodaran, Ishwary, et al.
Published: (2020)